• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.04% Nasdaq Down 0.66%

    Delcath Systems, Inc. (DCTH)

    -NasdaqCM
    0.42 Up 0.02(4.17%) 9:44AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.40
    Open:0.42
    Bid:0.39 x 2400
    Ask:0.42 x 4000
    1y Target Est:1.30
    Beta:0.707955
    Earnings Date:Nov 3 - Nov 9 (Est.)
    Day's Range:0.42 - 0.42
    52wk Range:0.36 - 2.78
    Volume:17,972
    Avg Vol (3m):561,240
    Market Cap:9.08M
    P/E (ttm):N/A
    EPS (ttm):-1.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for DCTH

    Comparison

    Symbol% ChgMkt Cap
    DCTHUp 4.17%9.08M
    LLYUp 1.26%89.21B
    PFEDown 0.37%200.69B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.14
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:4.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback